Get startedLog in
    Picture of Tianjin TEDA Biomedical Engineering Co logo

    8189 — Tianjin TEDA Biomedical Engineering Co Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    Basic MaterialsHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Tianjin TEDA Biomedical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-88.8-50-44.8-26.5-17.6
    Depreciation
    Amortisation
    Non-Cash Items71.637.339.44.932.77
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-1.1741.5-10.7-6.64-9.95
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-3.836-6.68-12.8-13.2
    Capital Expenditures-1.24-14-33.7-8.8-2.47
    Purchase of Fixed Assets
    Other Investing Cash Flow Items10.1-12.525.2-4.132
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities8.87-26.5-8.51-12.9-0.467
    Financing Cash Flow Items0————
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-24-20.228.16.1712.7
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-18.9-10.712.9-19.6-0.893